[SIME] QoQ Annualized Quarter Result on 31-Mar-2024 [#3]

Announcement Date
23-May-2024
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2024
Quarter
31-Mar-2024 [#3]
Profit Trend
QoQ- -25.45%
YoY- 284.81%
View:
Show?
Annualized Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 67,132,000 64,452,000 59,056,000 55,920,000 48,288,000 46,669,333 46,948,000 26.95%
PBT 2,181,000 2,377,333 2,360,000 2,912,000 1,878,000 1,421,333 1,410,000 33.78%
Tax 1,348,000 2,126,666 3,516,000 -520,000 -366,000 -253,333 -164,000 -
NP 3,529,000 4,504,000 5,876,000 2,392,000 1,512,000 1,168,000 1,246,000 100.30%
-
NP to SH 3,306,000 4,289,333 5,754,000 2,356,000 1,458,000 1,114,666 1,192,000 97.52%
-
Tax Rate -61.81% -89.46% -148.98% 17.86% 19.49% 17.82% 11.63% -
Total Cost 63,603,000 59,948,000 53,180,000 53,528,000 46,776,000 45,501,333 45,702,000 24.67%
-
Net Worth 19,357,439 1,915,295,960 19,084,799 16,631,040 16,903,680 15,881,279 15,801,519 14.50%
Dividend
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Div 886,080 27,264,000 408,960 - 886,080 272,640 408,660 67.60%
Div Payout % 26.80% 635.62% 7.11% - 60.77% 24.46% 34.28% -
Equity
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Net Worth 19,357,439 1,915,295,960 19,084,799 16,631,040 16,903,680 15,881,279 15,801,519 14.50%
NOSH 6,812,157 6,812,157 6,812,157 6,812,157 6,812,157 6,812,157 6,812,157 0.00%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 5.26% 6.99% 9.95% 4.28% 3.13% 2.50% 2.65% -
ROE 17.08% 0.22% 30.15% 14.17% 8.63% 7.02% 7.54% -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 984.92 9.46 866.43 820.42 708.45 684.70 689.30 26.88%
EPS 48.50 62.93 84.40 34.40 21.40 16.27 17.40 98.18%
DPS 13.00 4.00 6.00 0.00 13.00 4.00 6.00 67.51%
NAPS 2.84 2.81 2.80 2.44 2.48 2.33 2.32 14.44%
Adjusted Per Share Value based on latest NOSH - 6,812,157
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 985.47 946.13 866.92 820.89 708.85 685.09 689.18 26.95%
EPS 48.53 62.97 84.47 34.59 21.40 16.36 17.50 97.50%
DPS 13.01 400.23 6.00 0.00 13.01 4.00 6.00 67.60%
NAPS 2.8416 281.1585 2.8016 2.4414 2.4814 2.3313 2.3196 14.50%
Price Multiplier on Financial Quarter End Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 -
Price 2.62 2.60 2.35 2.21 2.05 2.15 2.30 -
P/RPS 0.27 27.50 0.27 0.27 0.29 0.31 0.33 -12.53%
P/EPS 5.40 413.16 2.78 6.39 9.58 13.15 13.14 -44.75%
EY 18.51 0.24 35.92 15.64 10.43 7.61 7.61 80.96%
DY 4.96 1.54 2.55 0.00 6.34 1.86 2.61 53.48%
P/NAPS 0.92 0.93 0.84 0.91 0.83 0.92 0.99 -4.77%
Price Multiplier on Announcement Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 27/08/24 23/05/24 21/02/24 27/11/23 24/08/23 24/05/23 23/02/23 -
Price 2.55 2.90 2.66 2.38 2.11 2.12 2.28 -
P/RPS 0.26 30.67 0.31 0.29 0.30 0.31 0.33 -14.70%
P/EPS 5.26 460.83 3.15 6.89 9.86 12.96 13.03 -45.40%
EY 19.02 0.22 31.74 14.52 10.14 7.71 7.68 83.14%
DY 5.10 1.38 2.26 0.00 6.16 1.89 2.63 55.56%
P/NAPS 0.90 1.03 0.95 0.98 0.85 0.91 0.98 -5.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment